about
Targeting metabolic reprogramming in KRAS-driven cancers.ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cellsCancer Cell Plasticity: Rapid Reversal of Chemosensitivity and Expression of Stemness Markers in Lung and Breast Cancer Tumorspheres.Inhibition of retinoic acid receptor β signaling confers glycolytic dependence and sensitization to dichloroacetate in melanoma cells.Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma.Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research.Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.IDH2 deficiency accelerates skin pigmentation in mice via enhancing melanogenesis.SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway.Pseudotime Dynamics in Melanoma Single-Cell Transcriptomes Reveals Different Mechanisms of Tumor Progression.The oxidoreductase p66Shc acts as tumor suppressor in BRAFV600E-transformed cells.Deciphering the Dichotomous Effects of PGC-1α on Tumorigenesis and Metastasis.Amino Acid Signature in Human Melanoma Cell Lines from Different Disease Stages.Benzylamine and Thenylamine Derived Drugs Induce Apoptosis and Reduce Proliferation, Migration and Metastasis Formation in Melanoma Cells
P2860
Q38710288-54BB4BF3-55AB-4B45-9FE6-BA9F59214417Q42211295-134F242D-2132-4248-B939-DB94CF14D739Q45048442-14C593AF-7711-4A1F-AEFD-BA5EECC2AFF0Q47118007-A4B7EDD3-45F9-4CA9-9C35-3E58DD9DD859Q47135720-D083844E-AEE4-4316-81CC-482C2AE69A3BQ47197940-39244B44-F918-44DA-BA5C-C0837A33A939Q47225640-2FA25DF7-768B-4BB0-AD26-F7318EB9890AQ47759599-74F2961B-06F3-4EC8-8A4E-0B6B0843DA4EQ51023212-5661286B-8033-4B5F-9A6E-7361987E59AAQ52320159-2A8669E6-A5B8-4EA0-B820-5C79EBBA6922Q52663598-9D594357-1717-41CE-9824-A228F2FFCDA6Q52722046-5CFD4DED-770F-4D92-AB6F-73A6B6196E43Q53697878-DE284693-AA24-4470-B294-12AEC0AD0345Q55008290-00371B41-107F-4956-922F-C6B9DDAF551AQ55091781-98AB80C0-5624-4044-AF12-0EABB592A1CBQ58712892-410B335A-3167-48F5-A4E8-73FBED519ECB
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metabolic rewiring in melanoma
@ast
Metabolic rewiring in melanoma
@en
Metabolic rewiring in melanoma
@nl
type
label
Metabolic rewiring in melanoma
@ast
Metabolic rewiring in melanoma
@en
Metabolic rewiring in melanoma
@nl
prefLabel
Metabolic rewiring in melanoma
@ast
Metabolic rewiring in melanoma
@en
Metabolic rewiring in melanoma
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Metabolic rewiring in melanoma
@en
P2093
A L Osterman
B I Ratnikov
P2860
P2888
P3181
P356
10.1038/ONC.2016.198
P407
P577
2016-06-06T00:00:00Z
2017-01-12T00:00:00Z
P6179
1028401946